Tag Archives: Cannabidiol

Scotland in Line for Multi-Million Pound Boost From New Cannabis Industry

Scotland in Line for Multi-Million Pound Boost From New Cannabis Industry

Scotland in Line for Multi-Million Pound Boost From New Cannabis Industry

Scotland is set for a multi-million pound boon from the cannabis industry after a worldwide health agency confirmed that the drug provides medicinal relief for a range of ailments.

The Hawkeye State to Welcome First Iowa Medical Cannabidiol Company

Hawkeye State to Welcome First Iowa Medical Cannabidiol Company

The Hawkeye State is preparing to welcome the first Iowa medical cannabidiol company into the state’s medical cannabidiol program.. On Nov. 28, 2017, the Iowa Department of Public Health announced its intent to award a medical cannabidiol manufacturer license to MedPharm Iowa, a company based in Des Moines.

MedPharm Iowa to Serve as First Medical Cannabidiol Company in Iowa

DES MOINES, Iowa, Nov. 28, 2017 /Weed Wire/ — Today the Iowa Department of Public Health issued a notice of intent to award a manufacturing license to manufacture medical cannabidiol in Iowa to MedPharm Iowa, LLC.

AG Curtis Hill: Cannabidiol (CBD) Products are Illegal in Indiana

INDIANAPOLIS, Ind., Nov. 21, 2017 /Weed Wire/ — Attorney General Curtis Hill today released the following statement in conjunction with the issuance of an advisory opinion from his office regarding the legality of cannabidiol products.

First Cannabis-Based Product Gets Approval to Air Commercial on Nationally Syndicated Networks

CONWAY, S.C., Nov. 20, 2017 /Weed Wire/ — One of America’s leading cannabidiol companies has received approval to air the nation’s first cannabis-based product advertising. Ads for Palmetto Harmony begin airing Monday on several national networks, including but not limited to: Oxygen, Lifetime Movies, WE, FYI, BBC-America, Centric, Freeform, GAC, UP, and 71 local market affiliates for ABC, NBC, CBS, and Fox.

Federal Legislation: Cannabidiol Research Expansion Act Introduced

Federal Legislation: Cannabidiol Research Expansion Act Introduced

On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.

Feinstein, Grassley Introduce Bill to Expand Research into Medical Benefits of Cannabidiol and Marijuana

WASHINGTON, May 25, 2017 /Weed Wire/ — Senators Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), leaders of the Senate Caucus on International Narcotics Control, today introduced the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.


Cannabis Derivative Cannabidiol Reduces Seizures in Severe Epilepsy Disorder

NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.


ASX Medicinal Cannabis Company Signs Exclusive Strategic Alliance with US-Based Pharmaceutical Company

SYDNEY, Australia, May 24, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that it has signed an exclusive Strategic Alliance with Colorado-based healthcare solutions company Phoenix Life Sciences Inc (“Phoenix Life”) to collaboratively research, develop, manufacture, distribute and sell medicinal cannabis products in Australia and internationally.

Congressman Perry Introduces Bill to Help Epileptic Children

WASHINGTON, May 1, 2017 /Weed Wire/ – Continuing his fight to help families with children suffering from debilitating forms of epilepsy, Congressman Scott Perry joined with Senator Corey Gardner (R-CO) to reintroduce the Charlotte’s Web Medical Access Act of 2017.

Forbes Magazine HempLife Today - Forbes Magazine Ubiquitech

HempLife Today Announces Free Trial Pack of CannazALL CBD GelCaps to All Existing Shareholders, Their Families and Friends

DENVER, April 6, 2017 /Weed Wire/ — Ubiquitech Software Corp. (OTC PINK: UBQU), through its subsidiary HempLife Today, an innovative and growing Company offering the finest CBD (Cannabidiol) products derived from Hemp, is announcing that it is giving away a free trial pack of six (6) CannazALL™ CBD GelCaps to all existing shareholders, their families and friends.


Zynerba Pharmaceuticals Announces Completion of Enrollment for ZYN002 in Two Phase 2 Clinical Trials for Epilepsy and Osteoarthritis

DEVON, Penn., March 13, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has completed enrollment in the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 cannabidiol (CBD) gel in adult epilepsy patients with refractory focal seizures.


Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S.

WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”

Georgia Senate Bill Places New Restriction on THC Levels in Cannabis Oil

The Georgia Senate has passed a bill that would require a reduction in the amount of THC in cannabis oil. Senate Bill 16 reduces the amount of THC, the psychoactive chemical in marijuana, allowed in cannabis oil from 5 percent to 3 percent. However, the bill also adds a medical condition, autism, to the eight legal uses of medical marijuana established in 2015.

Brazilian Supreme Court Justice Calls For Legalization of Marijuana

Brazilian Supreme Court Justice Calls For Legalization of Marijuana

A justice on the Brazilian Supreme Court has called for the legalization of marijuana and even harder drugs as a means to ending violence among drug gangs, according to a Feb. 10, 2017, article from Reuters. The justice, Roberto Barroso, is a constitutional law professor who was educated at Yale University in the United States.


Marijuana Enforcement Acts on Retail Violations

ANCHORAGE, Feb. 9, 2017 /Weed Wire/ — Today, enforcement officers of the Alcohol and Marijuana Enforcement Office seized items from several retail stores across the state containing CBD (cannabidiol) oil that appear to be offered for sale in violation of several provisions of AS 17.38, including requirements for testing, packaging, and labeling.

'Cannabis in Parkinson's Disease: Growing Like a Weed!'

‘Cannabis in Parkinson’s Disease: Growing Like a Weed!’

“Cannabis in Parkinson’s Disease: Growing Like a Weed!” was presented at the University of Colorado School of Medicine’s Neurology Grand Rounds on Jan. 18, 2017.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana Inc. Subsidiary Kannaway® Announces Launch of a New Product— “Kannaway® Gold Premium Hemp Oil”

SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.

Washington State Bill Would Allow Medical Marijuana at Public Schools

Washington State Bill Would Allow Medical Pot at Public Schools

The father of a first-grade student in Aberdeen, Washington, could become the catalyst for a change in state law that would allow CBD oil at public schools. River Barclay, 7, needs CBD oil to manage a rare form of epilepsy, but state law will not allow her father to go to the school to administer the dose because medical marijuana is illegal on school property.

Law Firm Challenges New DEA Rule on Cannabidiol

Law Firm Challenges New DEA Rule on Cannabidiol

On Jan. 16, 2017, the Denver-based law firm Hoban Law Group, which represents several clients in the hemp industry, announced that it had filed a petition with the United States Court of Appeals for the Ninth Circuit to challenge a new DEA rule that would make cannabidiol illegal.

Some Wisconsin Republicans Warming to Medical Marijuana

Some Wisconsin Republicans Warming to Medical Marijuana

Some Wisconsin Republicans who have been opposed to medical marijuana are now warming to the idea of legalizing cannabidiol or CBD oil, according to an article by the Associated Press. Republican state Sen. Van Wanggaard said he wants to introduce a bill allowing possession and use of CBD oil, which has proven to help people with seizures.

Idaho Moms For Marijuana Protester Cited in State Capital

Idaho Moms For Marijuana Protester Cited in State Capital

Serra Frank was protesting in Boise, Idaho, with Idaho Moms for Marijuana during the second annual New Year’s Smoke Out Protest on Jan. 1, 2016. At 4:20 p.m., she was cited for misdemeanor possession of a controlled substance and possession of paraphernalia, and gave her marijuana to the police, according to Jan. 1, 2016 articles in local media.

DEA Issues New Rule to Ban Cannabidiol

DEA Issues New Rule to Ban Cannabidiol

On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more cannabinoids are now considered a schedule I substance.

CBA Five years SAM Cannabis Business Alliance CBA

CBA statement: DEA Rescheduling of Cannabidiol (CBD) Irrational and Irresponsible

DENVER, Dec. 15, 2016 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement on the recent reports of the United States Drug Enforcement Administration’s rescheduling of all marijuana extracts, including CBD oil as Schedule I controlled substances.

Linebacker Wants NFL to Consider CBD Oil For Brain Protection

Linebacker Wants NFL to Consider CBD Oil For Brain Protection

Tennessee Titans linebacker Derrick Morgan is the only active NFL player calling on the league to investigate the merits of cannabidiol, or CBD oil, according to a report at CBSNews.com. Morgan has not used CBD oil, a non-psychoactive chemical from marijuana, because he does not want to risk violating NFL rules on substance abuse.

Olá R&D: Bedrocan Canada Exports Medical Cannabis to Brazil

Olá R&D: Bedrocan Canada Exports Medical Cannabis to Brazil

On Nov. 23, 2016, Canopy Growth Corporation (TSX:CGC) announced that Bedrocan Canada, one of its subsidiaries, had completed its first export of cannabis to South America, shipping 10 kg of dried cannabis to Brazil for the research and development of cannabis-based therapeutics in the country.


New Report: U.S. CBD Sales to Reach $2.1B by 2020 With $450M From Hemp Industry

BOULDER, Colo., Oct. 25, 2016 /Weed Wire/ — The Hemp Business Journal (HBJ), the hemp industry’s authority on big data and market intelligence, has released The CBD Report showing cannabidiol as one of the fastest growing market categories in the U.S. hemp and legal marijuana industries with a compound annual growth rate of 59%.

Cannabis & Parkinson's Disease Study Preps for Launch

Cannabis & Parkinson’s Disease Study Preps for Launch

On Oct. 2, 2016, Maureen Leehey, MD, discussed the potential of cannabis in treating Parkinson’s disease at the 3rd Annual Parkinson’s Disease Symposium at the University of Colorado Movement Disorders Center.

Third win for cannabis drug in epilepsy sends GW to record high

Third Win for Cannabis Drug in Epilepsy Sends GW to Record High

An experimental cannabis-derived drug has successfully treated children with severe epilepsy in a third late-stage clinical trial, sending shares in Britain’s GW Pharmaceuticals to a record high on Monday.

Hometowne Rx

Leonard Marshall Partners With Hometowne RX For Cannabis-Based Medicine

Leonard Marshall, former defensive end for the New York Giants, has partnered with a small pharmacy chain in New Jersey to make cannabis-based medicines if the state legalizes pot, according to an article in the New York Daily News. Aisha Bhatti, director of pharmacy for Hometowne Rx, said her company is “watching the trends” with legalization.


CBD Incorporated to Build “Liquid Gold Factory,” Offers Investment Opportunity

CALABASAS, Calif., July21, 2016 /Weed Wire/ — CBD Incorporated, a Southern California-based startup, has been formed to capitalize on the exponentially growing cannabis market by focusing on what the company believes to be the most promising compound in cannabis.


Major Hemp and Ute Pass Develop Hemp Craft Beer for Summer Release

California-based Major Hemp, a subsidiary of Sipp Industries, has joined forces with Colorado’s Ute Pass Brewing Co. for the production of a hemp craft beer. A trial run of the craft beer, made with a proprietary recipe including hemp and a Cannabidiol infusion, is slated to be released in Colorado this summer.

GWPH Phase 3 Results

GW Pharmaceuticals Announces Positive Phase 3 Pivotal Study Results for Epidiolex® (cannabidiol)

LONDON, March 14, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome.

Page 1 of 212